🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will be an open-label, randomized, 3-way, 6-sequence crossover s...
Status
Completed
Location
Multiple Locations
Start Date
2010-12-01
Trial ID
NCT01249131
Treatments Being Tested
The proposed study conducted in adult and pediatric patients aims to evalua...
Status
Completed
Location
Institut de Cancérologie de l'Ouest
Start Date
2020-02-12
Trial ID
NCT04216953
Treatments Being Tested
This open-label, randomized, multicenter, triple-arm Phase Ib/II study is d...
Status
Completed
Location
Fakultni nemocnice Brno; Interni hematologicka a onkologicka klinika
Start Date
2017-11-13
Trial ID
NCT03312530
Treatments Being Tested
This is a Phase III, double-blinded, placebo-controlled, randomized, multic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-01-13
Trial ID
NCT02908672
Treatments Being Tested
This study will evaluate the efficacy and safety of cobimetinib plus atezol...
Status
Completed
Location
Instituto Nacional de Cancer - INCa; Oncologia
Start Date
2018-12-13
Trial ID
NCT03625141
Treatments Being Tested
This is a Phase 1, single-center, open-label, randomized, 3-period, 2-seque...
Status
Completed
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01277718
Treatments Being Tested
This is a single arm, multicenter, open label, and non-randomized clinical ...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-05-23
Trial ID
NCT02768207
Treatments Being Tested
DETERMINE is an open-label phase II/III trial. It will look at targeted tre...
Status
Recruiting
Location
Belfast City Hospital
Start Date
2023-03-01
Trial ID
NCT05722886
The purpose of this study is to evaluate the efficacy beyond progression of...
Status
Unknown
Location
Istituto dei Tumori "Giovanni Paolo II"
Start Date
2018-06-18
Trial ID
NCT03514901
Treatments Being Tested
This is a study to evaluate the efficacy, safety, and pharmacokinetics of c...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2017-11-23
Trial ID
NCT03264066
Treatments Being Tested